Kala Bio (KALA) Enterprise Value (2017 - 2026)

Kala Bio has disclosed Enterprise Value across 10 years of filings, most recently posting $19.2 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 98.77% year-over-year to $19.2 million; the TTM figure through Jun 2026 stood at $19.2 million (down 98.77% YoY), while the FY2025 annual figure was $219.0 million, down 82.7% from the prior year.
• Enterprise Value came in at $19.2 million for Q2 2026 at Kala Bio, down from $93.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $5.0 billion in Q1 2022 to a low of $19.2 million in Q2 2026.
• Average Enterprise Value over 5 years is $1.4 billion, with a median of $1.1 billion recorded in 2023.
• Year-over-year, Enterprise Value surged 69.95% in 2023 and tumbled 98.77% in 2026.
• Over 5 years, Enterprise Value stood at $3.2 billion in 2022, then plunged by 71.26% to $914.9 million in 2023, then soared by 38.38% to $1.3 billion in 2024, then slumped by 82.7% to $219.0 million in 2025, then plunged by 91.22% to $19.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $19.2 million in Q2 2026, $93.9 million in Q1 2026, and $219.0 million in Q4 2025.